Case report: marfan syndrome (MFS) mimicking cutaneous vasculitis

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder caused by variants in the extracellular microfibril fibrillin (FBN1) gene. Here we report an FBN1 variant in a child with an unusual skin rash mimicking cutaneous vasculitis, and mild aortic root dilatation. The case was complicated by lack of typical skeletal MFS phenotype; and severe needle phobia preventing any blood testing for workup of suspected vasculitis. Therefore inflammatory markers, autoantibody profile and general hematology/biochemistry results were unknown. Diagnosis of MFS was made via genetic testing of a saliva sample alone using a next-generation sequencing (NGS) targeted gene panel designed to screen for monogenic forms of vasculitis and noninflammatory vasculopathic mimics. This revealed the patient was heterozygous for a pathogenic frameshift variant in FBN1; NM_000138, c.1211delC, p.(Pro404Hisfs*44), predicted to cause premature protein truncation leading to loss of function. The variant has not been detected in control populations and has previously been detected in individuals with MFS. This rapid diagnosis significantly impacted the patient management: avoidance of invasive investigations; avoidance of unnecessary immunosuppression; facilitating genetic counselling of the index case and family; and directly informing lifelong monitoring and ongoing treatment for aortic root involvement from MFS. This case further emphasizes the diagnostic utility of NGS early in the diagnostic workup of paediatric patients referred with suspected vasculitis, and we emphasize that MFS can present with cutaneous vasculitic-like features in the absence of the typical Marfanoid skeletal phenotype.

[1]  D. Eleftheriou,et al.  Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification , 2022, Frontiers in Pediatrics.

[2]  G. Jondeau,et al.  Clinical relevance of genotype–phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants , 2021, Genetics in Medicine.

[3]  A. Boel,et al.  Cutis laxa: A comprehensive overview of clinical characteristics and pathophysiology , 2020, Clinical genetics.

[4]  S. Kamphuis,et al.  European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. , 2020, Rheumatology.

[5]  Melissa J. Landrum,et al.  ClinVar: improvements to accessing data , 2019, Nucleic Acids Res..

[6]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[7]  S. Kamphuis,et al.  European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative , 2018, Rheumatology.

[8]  C. Hack,et al.  Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics , 2018, European Journal of Medical Research.

[9]  Helena Ahlfors,et al.  Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis , 2017, PloS one.

[10]  A. Mani,et al.  The Genetics of Aortopathies in Clinical Cardiology , 2017, Clinical Medicine Insights. Cardiology.

[11]  G. Pals,et al.  Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome , 2017, Heart.

[12]  Jill L. Maron,et al.  Salivary Diagnostics in Pediatrics: Applicability, Translatability, and Limitations , 2017, Front. Public Health.

[13]  S. Blankenberg,et al.  Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse☆ , 2016, International journal of cardiology. Heart & vasculature.

[14]  Ha Won Kim,et al.  Activated STING in a vascular and pulmonary syndrome. , 2014, The New England journal of medicine.

[15]  R. Bergman,et al.  Atrophic skin patches with abnormal elastic fibers as a presenting sign of the MASS phenotype associated with mutation in the fibrillin 1 gene. , 2014, JAMA dermatology.

[16]  J. Mullikin,et al.  Early-onset stroke and vasculopathy associated with mutations in ADA2. , 2014, The New England journal of medicine.

[17]  Laurence Faivre,et al.  The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.

[18]  Christian Baumgartner,et al.  A bioinformatics framework for genotype-phenotype correlation in humans with Marfan syndrome caused by FBN1 gene mutations , 2006, J. Biomed. Informatics.

[19]  P. Robinson,et al.  The molecular genetics of Marfan syndrome and related disorders , 2006, Journal of Medical Genetics.

[20]  A. Wakhlu,et al.  Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes , 2017, Rheumatology International.